(Q43561078)

24 November 2017

title

Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung (English)

1 reference

24 November 2017

1 reference

Hope E Karnes

1

1 reference

24 November 2017

Eric J Duncavage

series ordinal

2

1 reference

24 November 2017

Cory T Bernadt

series ordinal

3

1 reference

24 November 2017

publication date

12 November 2013

1 reference

24 November 2017

1 reference

24 November 2017

volume

122

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

104-113

1 reference

Chemotherapy for advanced stage non-small cell lung cancer

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Molecular pathology of non-small cell lung cancer: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

ROS1 rearrangements in lung cancer: a new genomic subset of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

ROS1 rearrangements define a unique molecular class of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

MET signaling: novel targeted inhibition and its clinical development in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

KIF5B-RET fusions in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Clonal architecture of secondary acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Global mutational profiling of formalin-fixed human colon cancers from a pathology archive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

CREST maps somatic structural variation in cancer genomes with base-pair resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Accurate and exact CNV identification from targeted high-throughput sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Absolute quantification of somatic DNA alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

The Sequence Alignment/Map format and SAMtools

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

BEDTools: a flexible suite of utilities for comparing genomic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

A framework for variation discovery and genotyping using next-generation DNA sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Next generation sequencing in cancer research and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

New approaches to molecular diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Next-generation DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Key principles and clinical applications of "next-generation" DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

Whole-genome analysis informs breast cancer response to aromatase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21361

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCY.21361

1 reference

24 November 2017

1 reference